Amyloid β Protein Dimer-Containing Human CSF Disrupts Synaptic Plasticity: Prevention by Systemic Passive Immunization

The current development of immunotherapy for Alzheimer's disease is based on the assumption that human-derived amyloid β protein (Aβ) can be targeted in a similar manner to animal cell-derived or synthetic Aβ. Because the structure of Aβ depends on its source and the presence of cofactors, it i...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Klyubin, Igor, Betts, Vicki, Welzel, Alfred T., Blennow, Kaj, Zetterberg, Henrik, Wallin, Anders, Lemere, Cynthia A., Cullen, William K., Peng, Ying, Wisniewski, Thomas, Selkoe, Dennis J., Anwyl, Roger, Walsh, Dominic M., Rowan, Michael J.
Format: Artigo
Idioma:Inglês
Publicat: Society for Neuroscience 2008
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2685151/
https://ncbi.nlm.nih.gov/pubmed/18417702
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.5161-07.2008
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars